CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 193 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $354,799,680 | +12.0% | 6,548,536 | +44.9% | 0.02% | +14.3% |
Q1 2024 | $316,922,299 | -35.6% | 4,520,358 | -23.3% | 0.01% | -41.7% |
Q4 2023 | $492,036,459 | +216.7% | 5,893,358 | +11.7% | 0.02% | +166.7% |
Q3 2023 | $155,386,358 | -6.4% | 5,274,486 | +3.6% | 0.01% | 0.0% |
Q2 2023 | $166,087,340 | -0.7% | 5,091,580 | +7.1% | 0.01% | 0.0% |
Q1 2023 | $167,289,741 | -63.8% | 4,753,900 | -52.9% | 0.01% | -35.7% |
Q4 2022 | $462,315,918 | +124.2% | 10,089,828 | +137.1% | 0.01% | +7.7% |
Q3 2022 | $206,161,000 | +16.5% | 4,255,125 | -5.5% | 0.01% | +18.2% |
Q2 2022 | $176,971,000 | +14.6% | 4,504,226 | +7.3% | 0.01% | +37.5% |
Q1 2022 | $154,485,000 | -15.0% | 4,196,832 | +5.3% | 0.01% | -11.1% |
Q4 2021 | $181,647,000 | +17.9% | 3,985,227 | -7.5% | 0.01% | +12.5% |
Q3 2021 | $154,050,000 | +83.1% | 4,310,288 | +1.4% | 0.01% | +100.0% |
Q2 2021 | $84,123,000 | -12.7% | 4,250,786 | +2.6% | 0.00% | -33.3% |
Q1 2021 | $96,342,000 | -0.1% | 4,141,970 | -10.8% | 0.01% | 0.0% |
Q4 2020 | $96,438,000 | +17.8% | 4,640,923 | +22.8% | 0.01% | 0.0% |
Q3 2020 | $81,843,000 | +14.2% | 3,780,260 | +24.3% | 0.01% | +20.0% |
Q2 2020 | $71,677,000 | +126.4% | 3,041,032 | +13.2% | 0.01% | +66.7% |
Q1 2020 | $31,663,000 | +17.5% | 2,685,562 | +5.7% | 0.00% | +50.0% |
Q4 2019 | $26,947,000 | +2.0% | 2,539,766 | +9.4% | 0.00% | 0.0% |
Q3 2019 | $26,412,000 | -2.8% | 2,320,879 | -4.0% | 0.00% | 0.0% |
Q2 2019 | $27,186,000 | +64.6% | 2,416,514 | +18.3% | 0.00% | +100.0% |
Q1 2019 | $16,520,000 | +36.4% | 2,042,077 | +6.6% | 0.00% | 0.0% |
Q4 2018 | $12,109,000 | -38.6% | 1,915,962 | -4.3% | 0.00% | -50.0% |
Q3 2018 | $19,717,000 | +16.1% | 2,001,562 | -2.1% | 0.00% | +100.0% |
Q2 2018 | $16,978,000 | -0.2% | 2,045,301 | -13.4% | 0.00% | 0.0% |
Q1 2018 | $17,005,000 | -23.2% | 2,361,612 | -13.0% | 0.00% | -50.0% |
Q4 2017 | $22,139,000 | -16.8% | 2,715,972 | +48.0% | 0.00% | 0.0% |
Q3 2017 | $26,615,000 | +31.4% | 1,835,515 | +9.6% | 0.00% | 0.0% |
Q2 2017 | $20,259,000 | +69.1% | 1,674,335 | +79.6% | 0.00% | +100.0% |
Q1 2017 | $11,981,000 | +9.8% | 932,426 | +3.9% | 0.00% | 0.0% |
Q4 2016 | $10,908,000 | +22.1% | 897,748 | -7.8% | 0.00% | 0.0% |
Q3 2016 | $8,936,000 | +51.2% | 973,200 | +56.2% | 0.00% | 0.0% |
Q2 2016 | $5,911,000 | +53.7% | 623,246 | +14.3% | 0.00% | – |
Q1 2016 | $3,845,000 | -54.1% | 545,460 | -31.9% | 0.00% | -100.0% |
Q4 2015 | $8,380,000 | +127.2% | 801,211 | +45.4% | 0.00% | – |
Q3 2015 | $3,689,000 | -0.1% | 551,038 | +0.3% | 0.00% | – |
Q2 2015 | $3,694,000 | +1.8% | 549,615 | +2.7% | 0.00% | – |
Q1 2015 | $3,629,000 | -11.0% | 535,333 | +5.1% | 0.00% | – |
Q4 2014 | $4,079,000 | +129.5% | 509,167 | +1.1% | 0.00% | – |
Q3 2014 | $1,777,000 | -24.7% | 503,490 | +2.1% | 0.00% | – |
Q2 2014 | $2,360,000 | -49.2% | 493,368 | +0.9% | 0.00% | -100.0% |
Q1 2014 | $4,648,000 | +72.1% | 489,174 | +9.2% | 0.00% | – |
Q4 2013 | $2,701,000 | -5.9% | 447,932 | +18.6% | 0.00% | – |
Q3 2013 | $2,869,000 | -14.1% | 377,687 | +30.8% | 0.00% | – |
Q2 2013 | $3,340,000 | – | 288,734 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |